32 results
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
, any Common
B-2
Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole … Act, or pursuant to an available exemption from registration, and agrees not to engage in hedging transactions with regard to the Securities unless
424B3
ALGS
Aligos Therapeutics Inc
28 Nov 23
Prospectus supplement
4:01pm
or other hedging transactions, whether through an options exchange or otherwise;
through agreements between broker-dealers and the Selling Securityholders … .
In connection with the sale of our shares of common stock or interests therein, the Selling Securityholders may enter into hedging transactions with broker
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
or indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement
B-2
that transfers to another
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part
S-1
EX-10.5
hf9ce
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.1
f4zb6tymx
25 Sep 20
IPO registration
5:27pm
PRE 14A
bud2tjne pnba9ym7
16 Apr 24
Preliminary proxy
5:27pm
S-1
x5l4zbd8 xukca
25 Sep 20
IPO registration
5:27pm
424B4
7gg9 hpfq
19 Oct 20
Prospectus supplement with pricing info
5:21pm
DRS
wzi48o6qqwys0qk
26 Aug 20
Draft registration statement
12:00am
424B4
4dm kvijwtg6
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DRS
hb8xx7e2kbclmhyj8wt5
4 Jun 21
Draft registration statement
12:00am
10-K
1nswuaecbyxmn
23 Mar 21
Annual report
4:26pm